Nimodipine prevents memory impairment caused by nitroglycerin-induced hypotension in adult mice.

Anesthesia and Analgesia
Alex BekkerThomas Blanck

Abstract

Hypotension and a resultant decrease in cerebral blood flow have been implicated in the development of cognitive dysfunction. We tested the hypothesis that nimodipine (NIMO) administered at the onset of nitroglycerin (NTG)-induced hypotension would preserve long-term associative memory. The passive avoidance (PA) paradigm was used to assess memory retention. For PA training, latencies (seconds) were recorded for entry from a suspended platform into a Plexiglas tube where a shock was automatically delivered. Latencies were recorded 48 h later for a testing trial. Ninety-six Swiss-Webster mice (30-35 g, 6-8 wk), were randomized into 6 groups 1) saline (control), 2) NTG immediately after learning, 3) NTG 3 h after learning, 4) NTG and NIMO, 5) vehicle, and 6) NIMO alone. The extent of hypotension and changes in brain tissue oxygenation (PbtO(2)) and in cerebral blood flow were studied in a separate group of animals. All groups exhibited similar training latencies (17.0 +/- 4.6 s). Mice subjected to hypotensive episodes showed a significant decrease in latency time (178 +/- 156 s) compared with those injected with saline, NTG + NIMO, or delayed NTG (580 +/- 81 s, 557 +/- 67 s, and 493 +/- 146 s, respectively). A Kruskal-Wallis 1-wa...Continue Reading

References

Nov 1, 1991·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Y YamauchiK Kogure
Mar 1, 1990·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Y YamauchiK Kogure
Nov 1, 1993·Behavioral and Neural Biology·D QuartermainJ Puente
Feb 1, 1997·Progress in Neuro-psychopharmacology & Biological Psychiatry·J MrsićJ Varljen
Oct 16, 1999·Anesthesiology·P Williams-RussoT Sculco
Jan 15, 2000·Science·J L McGaugh
Dec 22, 2000·Neurobiology of Learning and Memory·D QuartermainA Kwan
Dec 12, 2001·Neurology·G ZuccalàUNKNOWN GIFA-ONLUS Study Group [Grupo Italiano di Farmacoepidemiologia nell'Anzanio]
Jun 6, 2002·Cephalalgia : an International Journal of Headache·C TassorelliG Nappi
Jul 22, 2005·Lancet Neurology·Chengxuan QiuLaura Fratiglioni
Dec 24, 2005·Shock·J L Lomas-NieraAlfred Ayala
Nov 16, 2006·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Stefan Duschek, Rainer Schandry
Oct 9, 2008·Dementia and Geriatric Cognitive Disorders·Philip Lin Kiat YapTze Pin Ng
Oct 14, 2008·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Seung Ho ChoiKi Jun Kim
Feb 6, 2009·Anesthesiology·Gene T YocumEric J Heyer
Feb 17, 2009·Anesthesiology
Mar 20, 2009·Journal of Neurosurgical Anesthesiology·Michael HaileAlex Bekker

❮ Previous
Next ❯

Citations

Jun 28, 2013·SpringerPlus·Rafael E ChaparroEnrico M Camporesi
Feb 13, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Eduardo ChaparroEnrico Camporesi
Feb 5, 2014·Expert Opinion on Pharmacotherapy·Jerry J FloresJohn H Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.